Design of Experiments-Guided Development of Gallic Acid-Loaded Transethosomal Chitosan Gels
Pharmaceutics · 11.11.2026 · 18 (11) · 1463
DOI: 10.3390/pharmaceutics18111463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 11.11.2026. Verfasst von Daniela Paula Prudņikova und 5 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon 2020 research and innovation program.
Abstract (Originalsprache)
Background/Objectives: Gallic acid (GA) is a natural phenolic acid with reported antioxidant, anti-inflammatory, and antibacterial properties, but its limited skin permeation restricts its topical application. Although previous studies have demonstrated the potential of transethosomal formulations to enhance dermal GA delivery, their liquid dispersion form hinders practical topical use.
Methods
The aim of this study was to investigate the effects of chitosan molecular weight, chitosan concentration, and transethosome proportion on the GA release, pH, and spreadability of GA-loaded transethosomal chitosan gel using a Design of Experiments (DoE)-guided approach. First, transethosomes were synthesized using the cold method and assessed for physicochemical properties, in vitro permeability, and physical stability. Next, transethosomal gels were prepared based on a three-level full factorial DoE model. The results were analyzed using polynomial regression modeling and sweet spot analysis. The model-predicted exploratory sweet-spot region was experimentally verified, followed by additional assessments of drug content and content uniformity, rheological properties, and short-term physical stability.
Results
GA-loaded transethosomes had a diameter of 167.3 ± 9.9 nm, an encapsulation efficiency of 71.6 ± 5.7%, and substantially higher in vitro permeability across Strat-M® synthetic membranes (2520.77 ± 66.93 µg/cm2 within 24 h) compared to aqueous GA solution. After incorporation into chitosan gel, GA release at 6 h ranged from 65.5% to 93.2%. Formulations showed pH values of 3.93–4.46 and spreadability of 12.6–122.7 cm2. Increased chitosan concentration reduced GA release and increased pH toward the target range, while higher chitosan concentration and molecular weight restricted spreading. Rheological characterization revealed shear-thinning behavior.
Conclusions
The DoE-guided approach supported exploratory screening of GA-loaded transethosomal chitosan gels and provided insights into the relationships between formulation composition, GA release, pH, and spreadability.
Förderung
- European Union’s Horizon 2020 research and innovation program
Zitieren
APA
Prudņikova, D. P., Odiņa, E., Teterovska, R., Brangule, A., Bandere, D., & Bārzdiņa, A. (2026). Design of Experiments-Guided Development of Gallic Acid-Loaded Transethosomal Chitosan Gels. Pharmaceutics, 18(11), 1463. https://doi.org/10.3390/pharmaceutics18111463
Vancouver
Prudņikova DP, Odiņa E, Teterovska R, Brangule A, Bandere D, Bārzdiņa A. Design of Experiments-Guided Development of Gallic Acid-Loaded Transethosomal Chitosan Gels. Pharmaceutics. 2026;18(11):1463. doi:10.3390/pharmaceutics18111463
BibTeX
@article{Prudikova2026,
author = {Prudņikova, Daniela Paula and Odiņa, Elizabete and Teterovska, Renāte and Brangule, Agnese and Bandere, Dace and Bārzdiņa, Ance},
title = {Design of Experiments-Guided Development of Gallic Acid-Loaded Transethosomal Chitosan Gels},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {11},
pages = {1463},
doi = {10.3390/pharmaceutics18111463}
}
EUVIMED